Saturday, September 12, 2026

Serum Uric Acid in the Diagnosis of Gout

Serum Uric Acid in the Diagnosis of Gout: Bedside Clinical Lecture Notes

Serum Uric Acid in the Diagnosis of Gout: Bedside Clinical Lecture Notes

Overview and Diagnostic Limitations

  • Not a Standalone Diagnostic Test:
    • Serum uric acid (SUA) alone cannot confirm or exclude an acute gout flare.
    • Asymptomatic hyperuricemia is common (>20% of men, 4% of women), and the vast majority of hyperuricemic individuals never develop clinical gout.
  • Acute Flare Dynamics and Diagnostic Pitfalls:
    • SUA levels frequently drop into the normal reference range during an acute attack.
    • The systemic acute-phase inflammatory response triggers increased renal clearance of uric acid.
    • A normal SUA level obtained during an acute flare carries low negative predictive value and does not rule out gout.

Gold Standard Diagnostic Method

  • Synovial Fluid Arthrocentesis:
    • Direct examination under compensated polarized light microscopy demonstrating intracellular, needle-shaped, negatively birefringent monosodium urate (MSU) crystals remains definitive.
    • Joint fluid aspiration is also essential to rule out concurrent septic arthritis or pseudogout (calcium pyrophosphate crystal deposition).

Clinical Decision-Making and Prediction Tools

  • Integrated Multimodal Assessment:
    • SUA must be interpreted strictly as one component of a comprehensive clinical evaluation.
  • Janssens Clinical Prediction Rule:
    • Validated scoring system for acute gout when joint aspiration is unfeasible:
    • Male sex (1 point)
    • Prior patient-reported gout attack (1 point)
    • Rapid symptom onset within 1 day (1 point)
    • Joint erythema and redness (1 point)
    • First metatarsophalangeal (MTP) joint involvement (1 point)
    • Hypertension or cardiovascular disease history (1 point)
    • Elevated serum uric acid level (1 point)
    • Interpretation: A score under 4 excludes acute gout in over 97% of patients.

Therapeutic Implications

  • Long-Term Management vs. Acute Flare:
    • Reserve SUA primarily for guiding the initiation and titration of urate-lowering therapy (ULT, such as allopurinol or febuxostat) after the acute flare resolves.
    • Do not initiate urate-lowering drugs during an active presentation based solely on an isolated SUA measurement.

Summary Takeaways

  • Aspirate joint fluid for crystal analysis whenever clinically feasible.
  • A normal SUA does not exclude acute gout; an elevated SUA does not prove acute gout.
  • Use validated predictive rules (such as the Janssens rule) when arthrocentesis is unavailable.
  • Treat SUA as a longitudinal titration target, not as an acute diagnostic gold standard.

Reference: Dalbeth N et al. Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis. Ann Rheum Dis. 2018;77(7):1048-1052. doi:10.1136/annrheumdis-2017-212288.

Calcium Replacement in Massive Transfusion

Massive Transfusion: VitaCal Calcium Replacement Massive Transfusion: VitaCal Calcium Replacement Purpose Prevent or treat trans...